Diagnostic Challenges in Hematopathology
April 3 - 5, 2019
Physicians Can Earn A Maximum Of 14.5 AMA PRA Category 1 Credits™
Physicians Can Earn A Maximum Of 14.5 SAM Credit Hours
Megan S. Lim, M.D., Ph.D.
Hospital of the University of Pennsylvania / Children’s Hospital of Philadelphia
Dr. Lim is the Director of the Joint Division of Hematopathology, Hospital of the University of Pennsylvania and the Children's Hospital of Philadelphia in the Department of Pathology and Laboratory Medicine, Director of the Hematopathology Fellowship Program, Interim Director of the Clinical Flow Cytometry Laboratory, and the Director of the Lymphoma Biology Program at the Abramson Cancer Center.
Dr. Lim received an M.D. from the University of Calgary and a Ph.D. in Molecular Oncology from the University of Calgary and National Cancer Institute Lab of Pathology jointly. Dr. Lim obtained her Hematopathology fellowship training at the National Cancer Institute after which she assumed a faculty position at the University of Toronto (1998-2000), the University of Utah (2000-2006), and the University of Michigan (2000-2015) before moving to the University of Pennsylvania in 2015. She has held numerous leadership positions and served on training and education committees for the Association for Molecular Pathology and the United States and Canadian Academy of Pathology. She is the Vice-Chair of the Non-Hodgkin Lymphoma Disease Committee of the Children’s Oncology Group and participates in integrated translational research in pediatric lymphoma. Her research interests are focused on elucidating mechanisms involved in lymphoma pathogenesis. She has participated and directed numerous CME activities for AMP, ASCP, CAP, and USCAP.
Nathanael Bailey, M.D.
University of Pittsburgh Medical Center
Dr. Bailey is an Associate Professor of Pathology in the Division of Hematopathology at the University of Pittsburgh Medical Center. Prior to joining UPMC, he was an Assistant Professor at the University of Michigan, where he also directed the Molecular Genetic Pathology Fellowship Program. Dr. Bailey trained in molecular genetic pathology at the University of Michigan after completing an hematopathology fellowship and anatomic and clinical pathology residency training at West Virginia University. Dr. Bailey has coauthored numerous manuscripts, review articles, and book chapters on the molecular basis of hematolymphoid neoplasms. Dr. Bailey is especially interested in pathology education and has been awarded for his resident teaching. He has spoken at several regional and national meetings and is active in the United States and Canadian Academy of Pathology, the Association for Molecular Pathology, and the Society for Hematopathology.
Alejandro A. Gru, M.D.
University of Virginia
Dr. Gru is an Associate Professor of Pathology and Dermatology. He’s been at the University of Virginia since 2015, prior to which he was on the faculty at The Ohio State University. He did his residency training in Anatomic Pathology at Washington University in St. Louis School of Medicine, followed by fellowship training in Surgical Pathology, Hematopathology and Dermatopathology. He’s currently the section and fellowship program director of dermatopathology. He’s co-authored more than 120 peer-reviewed publications, and is the lead editor of two textbooks, ‘Hematopathology of the Skin’ and ‘Pediatric Dermatopathology and Dermatology’. Dr. Gru’s main area of expertise is in the field of skin lymphomas, pediatric dermatopathology, and melanocytic tumors. He’s on the editorial board of the American Journal of Surgical Pathology, BMC Cancer, Journal of Cutaneous Pathology, and Seminars in Diagnostic Pathology. He’s the pathology lead for the international PROCLIPI study and USCLC cancer registry. He serves on the advisory board for the Cutaneous Lymphoma Foundation the Board of Directors for the United States Cutaneous Lymphoma Consortium. He’s co-principal investigator for PROCLIPI and has been awarded with the private foundation endowment ‘Drs. Martin and Dorothy Spatz Foundation’ for his role on the PROCLIPI study.
Elaine S. Jaffe, M.D.
National Cancer Institute/NIH
Dr. Jaffe did her medical studies at Cornell University Medical College and the University of Pennsylvania, receiving the M.D. from the latter. Her residency and fellowship in pathology were completed at the National Cancer Institute, where she went on to become Chief of the Hematopathology Section of the Laboratory of Pathology.
Dr. Jaffe’s clinical and investigational studies have been intertwined to enhance our understanding of the malignant lymphomas. One of her earliest papers on follicular lymphoma (1974), a Citation Classic, presented evidence for the origin of this tumor from follicular B cells. More recently she described in situ follicular lymphomas, which provide insight into the earliest events of follicular lymphomagenesis, and identified histiocytic/dendritic cell tumors arising in follicular lymphoma, providing the first evidence for lineage plasticity in mature human lymphoid cells. She is an author of more than 600 peer reviewed articles, 40 invited editorials, and more than 150 chapters and invited reviews.
Dr. Jaffe was an Editor for both the 2001 and 2008 editions of the WHO Classification of Tumors of the Hematopoietic and Lymphoid Tissues and was one of four series editors overseeing the 4th Edition Series of Bluebooks for the classification of human tumors, under the auspices of the International Agency for Research on Cancer and the World Health Organization. Her textbook, Hematopathology, is now in its second edition. Dr. Jaffe has served on 21 journal editorial boards, including the USCAP journals, Modern Pathology and Laboratory Investigation, as well as The American Journal of Pathology, The American Journal of Surgical Pathology, Blood, and Cancer Research.
Science Watch named her among the 10 most highly cited researchers in clinical oncology from 1981 and 1998, and she was among the 400 most highly cited researchers in all Biomedical Sciences worldwide between 1996 and 2011. Dr. Jaffe has been president of both the Society for Hematopathology as well as the United States and Canadian Academy of Pathology. She has held several leadership positions in the American Society of Hematology. Among her awards are the Fred W. Stewart Award from Memorial-Sloan Kettering Cancer Center, the Lennert prize from the European Association for Haematopathology, the Maude Abbott Lecturer for the United States and Canadian Academy of Pathology, the Stratton medal from the American Society of Hematology, and the Rous Whipple Award from the American Society of Investigative Pathology in 2016. Dr. Jaffe was recognized for her outstanding mentoring abilities with awards from the National Cancer Institute and the American Society of Investigative Pathology. Dr. Jaffe was awarded an honorary degree (Honoris Causa) from the University of Barcelona, and received the Distinguished Graduate Award from the University of Pennsylvania School of Medicine in 2011.
In 1993, Dr. Jaffe was elected a fellow of the American Association for the Advancement of Science, and subsequently was elected Chair of the Medical Sciences Section of AAAS. She was elected to the Institute of Medicine of the National Academies – now the National Academy of Medicine - and currently serves as Membership Chair for Section 4 (Internal Medicine, Pathology and Dermatology).
Joseph D. Khoury, M.D.
University of Texas, MD Anderson Cancer Center
Dr. Khoury is a tenured Professor at The University of Texas MD Anderson Cancer Center in Houston, Texas, in the Department of Hematopathology. Dr. Khoury is the Executive Director of the MD Anderson Cancer Network for the Division of Pathology and Laboratory Medicine and the Director of the MD Anderson institutional Immunohistochemistry Laboratory. He is an expert in diagnostic hematopathology and translational research focused on hematolymphoid neoplasia. He has authored over 140 publications, 2 textbooks, and several book chapters. Dr. Khoury is the principal investigator of a funded research program and has trained numerous clinical and research fellows over the course of his practice. Dr. Khoury is also an active member of the College of American Pathologists where he currently serves as vice-chair of the Cancer Committee. He has lectured extensively at various institutions and conferences across the United States and the world.